Therapeutic targeting of the functionally elusive TAM receptor family
Dec 13, 2023
Therapeutic targeting of the functionally elusive TAM receptor family
Miao YR, Rankin EB, Giaccia, AJ. Nature Review Drug Discovery 2023
Miao YR, Rankin EB, Giaccia, AJ. Nature Review Drug Discovery 2023
Developing High-affinity Decoy Receptors to Treat Multiple Myeloma and Diffuse Large B Cell Lymphoma
Sep 5, 2022
Developing High-affinity Decoy Receptors to Treat Multiple Myeloma and Diffuse Large B Cell Lymphoma
Miao YR, Thakkar KN, Cenik, C, Jiang, D, Mizuno K, Jia C, Li CG, Zhao H, Diep A, Xu Y, Zhang XE, Yang, TC, Liedtke M, Abidi P, Leung, WS, Koong AC, Giaccia, AJ. J Exp Med 2022
Miao YR, Thakkar KN, Cenik, C, Jiang, D, Mizuno K, Jia C, Li CG, Zhao H, Diep A, Xu Y, Zhang XE, Yang, TC, Liedtke M, Abidi P, Leung, WS, Koong AC, Giaccia, AJ. J Exp Med 2022
Neutralization of PD-L2 is essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer.
Aug 1, 2021
Neutralization of PD-L2 is essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer.
Miao YR, Thakkar KN, Qian J, Kariolis, MS, Wei H, Nandagopal S, Yang T, Diep Anh, Cherf GM, Xu Y, Moon EJ, Xiao Y, Alemany H, Li T, Yu W, Wei B, Rankin E, Giaccia, AJ. Clin Can Res 2021 (Accepted for Publication)
Miao YR, Thakkar KN, Qian J, Kariolis, MS, Wei H, Nandagopal S, Yang T, Diep Anh, Cherf GM, Xu Y, Moon EJ, Xiao Y, Alemany H, Li T, Yu W, Wei B, Rankin E, Giaccia, AJ. Clin Can Res 2021 (Accepted for Publication)
S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma.
November, 2019
S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma.
Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB. Cancer Res 2019 Oct 4. pii: canres.1366 2019 (DOI: 10.1158/0008-5472.CAN-19-1366).
Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB. Cancer Res 2019 Oct 4. pii: canres.1366 2019 (DOI: 10.1158/0008-5472.CAN-19-1366).
Reprogramming the immunological microenvironment through radiation and targeting Axl.
Dec 23, 2016
Reprogramming the immunological microenvironment through radiation and targeting Axl.
Todd A Aguilera, Marjan Rafat, Laura Castellini, Hussein Shehade, Mihalis S Kariolis, Angela Bik-Yu Hui, Henning Stehr, Rie von Eyben, Dadi Jiang, Lesley G Ellies, Albert C Koong , Maximilian Diehn, Erinn B Rankin, Edward E Graves, Amato J Giaccia. Nat Commun. 2016 (DOI: 10.1038/ncomms13898)
Todd A Aguilera, Marjan Rafat, Laura Castellini, Hussein Shehade, Mihalis S Kariolis, Angela Bik-Yu Hui, Henning Stehr, Rie von Eyben, Dadi Jiang, Lesley G Ellies, Albert C Koong , Maximilian Diehn, Erinn B Rankin, Edward E Graves, Amato J Giaccia. Nat Commun. 2016 (DOI: 10.1038/ncomms13898)
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapy.
Nov 28, 2016
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapy.
Kariolis MS, Miao YR, Nash S, Jiang D, Diep A, Jones DS 2nd, Kapur S, Mathews II, Koong AC, Rankin EB, Cochran JR, Giaccia AJ. J Clin Invest 2016 (DOI: 10.1172/JCI85610).
Kariolis MS, Miao YR, Nash S, Jiang D, Diep A, Jones DS 2nd, Kapur S, Mathews II, Koong AC, Rankin EB, Cochran JR, Giaccia AJ. J Clin Invest 2016 (DOI: 10.1172/JCI85610).
An engineered Axl ‘decoy receptor’ effectively silences the Gas6/Axl signaling axis.
Nov 10, 2014
An engineered Axl ‘decoy receptor’ effectively silences the Gas6/Axl signaling axis.
Kariolis MS, Miao YR, Jones DS Jr., Kapur S, Mathews II, Giaccia AJ, Cochran JR. Nat Chem Biol 2014, (DOI: 10.1038/nchembio.1636).
Kariolis MS, Miao YR, Jones DS Jr., Kapur S, Mathews II, Giaccia AJ, Cochran JR. Nat Chem Biol 2014, (DOI: 10.1038/nchembio.1636).
